Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East

1

The study analyzed 91 COVID-19 cases in hematopoietic cell transplant patients from ten Middle East centers.
2

Patients had a median age of 35 years, with 42% being female and 52% having no prior comorbidities.
3

Eighty-six percent of patients exhibited symptoms, with fever being the most common, reported in 56% of cases.
4

Forty-eight percent of patients received COVID-19 directed therapies, while 52% did not receive any specific treatment.
5

The study aimed to evaluate the impact of various risk factors on the severity and outcomes of COVID-19 in this vulnerable population.

Bone Marrow Transplantation

by Riad El Fakih, Alfadil Haroon, Feras Alfraih, Murtadha K. Al-Khabori, Mohsen Alzahrani, Ahmad Alhuraiji, Abdulaziz Hamadah, Naif I. AlJohani, Bader Alahmari, Mohammed F. Essa, Ibraheem H. Motabi, Imran K. Tailor, Reem S. Almaghrabi, Khalil Al-Farsi, Ibraheem Abosoudah, Mouhab Ayas, Tusneem A. Elhassan, Ashraf M. Suhebeh, Syed Osman Ahmed, Saud Alhayli, Panayotis Kaloyannidis, Ahmad Alsaeed, Khalid Al Anezi, Sameer Alamoudi, Moussab Damlaj, Hani Al Hashmi, Mahmoud Aljurf
April 27, 2021

1